2014 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle View 
December 1, 2014Pernix Therapeutics Inc. to Present at the Oppenheimer Healthcare conference in New York, NY
November 24, 2014Pernix Therapeutics Inc. to Present at the 26th Annual Piper Jaffray Healthcare Conference
November 17, 2014Pernix Submits sNDA for TREXIMET® use in Adolescent Patients
November 10, 2014Pernix Therapeutics Reports Third Quarter 2014 Financial Results and Reaffirms Guidance
October 27, 2014Pernix Therapeutics to Report Q3 2014 Financial Results
August 20, 2014Pernix Therapeutics Closes on Acquisition of Treximet. Raises $220m Senior Notes. Issues Updated 2014 Guidance.
August 11, 2014PERNIX THERAPEUTICS REPORTS SECOND QUARTER 2014 FINANCIAL RESULTS
August 4, 2014Closing for PERNIX transaction to acquire TREXIMET® Tablets for Migraine from GSK Delayed
July 25, 2014PERNIX THERAPEUTICS TO REPORT SECOND QUARTER 2014 FINANCIAL RESULTS ON AUGUST 11, 2014
June 23, 2014PERNIX THERAPEUTICS APPOINTS CHIEF FINANCIAL OFFICER
May 14, 2014PERNIX signs agreement to acquire TREXIMET® Tablets for Migraine from GSK
May 12, 2014PERNIX THERAPEUTICS REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS
May 12, 2014PERNIX THERAPEUTICS TO REPORT FIRST QUARTER 2014 FINANCIAL RESULTS ON MAY 12, 2014
April 28, 2014PERNIX THERAPEUTICS APPOINTS TASOS KONIDARIS TO ITS BOARD OF DIRECTORS
April 25, 2014PERNIX CLOSES ON SALE OF MANUFACTURING FACILITY
April 21, 2014PERNIX THERAPEUTICS TO REPORT FIRST QUARTER 2014 FINANCIAL RESULTS ON MAY 12, 2014
April 17, 2014PERNIX ESTABLISHES NEW CORPORATE HEADQUARTERS
April 2, 2014PERNIX THERAPEUTICS TO PRESENT AT THE 13TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE
April 1, 2014PERNIX AGREES TO DIVEST MANUFACTURING FACILITY
March 18, 2014PERNIX THERAPEUTICS APPOINTS SENIOR VICE PRESIDENT OF SALES AND MARKETING
March 17, 2014PERNIX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS
March 13, 2014PERNIX THERAPEUTICS APPOINTS JOHN SEDOR TO ITS BOARD OF DIRECTORS
March 10, 2014PERNIX THERAPEUTICS APPOINTS CHIEF OPERATNG OFFICER
March 4, 2014PERNIX THERAPEUTICS APPOINTS VICE PRESIDENT OF COMPLIANCE
March 3, 2014PERNIX THERAPEUTICS TO REPORT FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS ON MARCH 17, 2014
February 27, 2014PERNIX SIGNS AGREEMENT WITH OSMOTICA PHARMACEUTICAL CORP TO PROMOTE KHEDEZLA™ (DESVENLAFAXINE ER) TABLETS, 50 MG AND 100 MG FOR MAJOR DEPRESSIVE DISORDER
February 24, 2014PERNIX CLOSES $65 MILLION INSTITUTIONAL INVESTMENT; AMENDS MIDCAP REVOLVER; MOVES TO RESHAPE BOARD OF DIRECTORS
February 5, 2014PERNIX ATTRACTS $65 MILLION INSTITUTIONAL INVESTMENT; APPOINTS DOUG DRYSDALE AS CEO; SETTLES PENDING LEGAL LIABILITIES